HERA medical countermeasures for CBRN threats – Medicinal products
Funds R&D on vaccines and drugs that protect against chemical, biological, radiological and nuclear threats.
The Commission structures this as an end-to-end pipeline rather than a single research grant: alongside the advanced R&D itself, it also expects proposals to involve end users and security practitioners to help bring the resulting countermeasures closer to market readiness, and to support market-readiness work or entrepreneurial and technical skills development. Within the biological-threat catego…
This topic funds advanced research and development of medicinal countermeasures against CBRN threats — vaccines and therapeutics such as antivirals, small molecules, antimicrobials and monoclonal or polyclonal antibodies for biological threats, plus antidotes and supportive treatments for chemical agents, and treatments for radiation exposure. It's aimed at threat-agnostic countermeasures and platform approaches that bridge the gap from research to market readiness, including tech and entrepreneurial skills support.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Find grantsGovernment Grants for Startups: What Deeptech Founders Should Know
A practical guide to government grants for startups, including Grants.gov, SBIR/STTR, state programs, eligibility, fit, timelines, and when to apply.
Write proposalGrant Proposal Abstract and Executive Summary: Examples That Work
Learn how to write a grant proposal abstract or executive summary, what to include, how it differs from a project summary, and how to use examples without copying.
More from HaDEA
All grants from this funder →AI and Health-Data Flagship for Cardiovascular and Related Disease Care
🇪🇺HaDEA · European Union
Funds a flagship project that federates EU health data and pilots AI tools for cardiovascular risk prediction, prevention and personalised care.
Cancer screening programmes for gastric cancer
🇪🇺HaDEA · European Union
Funds a stepwise rollout of gastric cancer screening programmes across EU Member States, including AI-assisted screening.
Coordinated access to European spaceports
🇪🇺HaDEA · European Union
Funds a study that proposes common rules and best practices so European launch providers can access any European spaceport more easily.
Digital enablers and building blocks for autonomous space transportation systems
🇪🇺HaDEA · European Union
Funds early-stage digital technology — health monitoring, smart avionics, AI data processing — that makes future launch systems more autonomous.
Digital solutions for space transportation autonomy — targeting demonstration
🇪🇺HaDEA · European Union
Funds on-ground or in-orbit demonstration of structural-damage detection and thermo-mechanical monitoring for reusable launch systems.
EU4Health Conferences and Events Grants
🇪🇺HaDEA · European Union
Funds not-for-profit, Union-wide conferences on EU health priorities that bring together policymakers, scientists and civil society.
Similar grants
Browse the directory →
Horizon Health: Bio-printing for Regenerative Medicine
🇪🇺European Commission · European Union
Funds €7–10M projects that advance living-cell bio-printing from laboratory proof toward regenerative medicine.
Biotech Call for Network Projects
🇦🇹EUREKA · Global / Multinational
Funds international biotech R&D consortia through each country's own national funding scheme.
Clinical trials for advancing innovative interventions for neurodegenerative diseases
🇪🇺European Commission · European Union
Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.
Pre-Commercial Procurement for Cancer Care
🇪🇺European Commission · European Union
Funds €8–10M procurer consortia to bring affordable cancer technologies, devices and medicines from tender to patient benefit.
Cancer Mission: Functional Genomics for New Treatments
🇪🇺European Commission · European Union
Funds €7–8M projects that use functional genomics and patient data to uncover precise new targets for difficult-to-treat cancers.
Clinical Research for Common Cancers
🇪🇺European Commission · European Union
Funds €7–10M programmes that bring better cancer diagnosis and treatment trials to patients across four or more European countries.